Korean J Obstet Gynecol.
2001 Jun;44(6):1165-1170.
A Comparison for Efficacy and Safety of Magnesium Sulfate(Magrose),
Ritodrine Hydrochloride(Yutopar) and Nifedipine(Adalat) in the Management of Preterm Labor
- Affiliations
-
- 1
Department of Obstetrics and Gynecology, Chonbuk National University
Hospital, Chonju, Chonbuk, Korea.
Abstract
OBJECTIVES
The aim of this study was to compare the efficacy and safety of magnesium sulfate, ritodrine hydrochloride and nifedipine in the management of preterm labor.
MATERIALS AND METHODS
180 women with documented preterm labor were randomly assigned to receive
magnesium sulfate (n=60), ritodrine hydrochloride (n=60) and nifedipine (n=60) as initial tocolytic therapy. 30
women with documented preterm labor were allocated to administer fluid only and bed rest as control group.
Patient could be switched to another tocolytic regimen if they continued to have contractions or side effects.
The main outcome variables examined were days gain in utero, success rate, side effects and neonatal
outcome.
RESULTS
There were no significant differences in maternal characteristics between the groups. The days
gain in utero was no statistically different in the three groups(magnesium sulfate, ritodrine hydrochloride and
nifedipine) but markedly longer in the three groups than the control group (p<.01). The total success rate was
similar in the three groups, but side effects were much more in the magnesium sulfate and ritodrine group
than the nifedipine group (p<.05). The respiratory distress syndrome in neonate was decreased in the three
groups than the control group without statistical significance.
CONCLUSION
Nifedipine is an effective, safe, and well-tolerated tocolytic agent. In this retrospective
study, total success rate of controlling preterm labor was similar in the three groups, but patients who received
nifedipine were less side effects than magnesium sulfate or ritodrine group.